ATRA - Atara gets FDA priority review for Tabelecleucel application July, 24 2025 10:49 AM Atara Biotherapeutics Inc. 2025-07-24 10:49:03 ET More on Atara Biotherapeutics Atara gains after insider purchase Atara Biotherapeutics prices $16M public offering Seeking Alpha’s Quant Rating on Atara Biotherapeutics Historical earnings data for Atara Biotherapeutics Financial information for Atara Biotherapeutics For further details see: Atara gets FDA priority review for Tabelecleucel application